ArticleBMC infectious diseases2025
The added value of diagnostics to characterize age-specific patterns of respiratory viral infections and coinfections and to detect emerging threats.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Delineating RSV-A and RSV-B: Epidemiological Patterns, Diagnostics, Clinical Severity, and Preventive Approaches.Journal of medical virology · 2026Review
- Diagnosis of Respiratory Infections Using Syndromic Panels: A Ct-Based Approach Beyond Qualitative Detection.Microorganisms · 2026Article
- Age-stratified respiratory viral detection patterns and exploratory environmental associations in a tertiary-care hospital testing cohort in Istanbul, Türkiye.Frontiers in microbiology · 2026Article
- Back to normality? Respiratory viruses, Mycoplasma pneumoniae, Chlamydophila pneumoniae, and Bordetella pertussis trends: local epidemiological update after the COVID-19 storm.Le infezioni in medicina · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
backgroundPandemic restrictions caused variation in respiratory virus circulation until the winter of 2022/23. The aim of this study was to monitor respiratory virus cases in the 2023/24 epidemic season.
methodsChildren and adults attending Sapienza University Hospital for acute respiratory infections (October 2023-June 2024) were tested for respiratory viruses via molecular methods.
resultsOf the 1121 patients included, 880 (78%) were positive for rhinovirus (HRV, 32%), Influenza A (IAV, 29%), and respiratory syncytial virus (RSV, 28%). RSV is more common in infants, and IAV is more common in adults, whereas HRV is more common in children aged 1-5 years. IAV, RSV and HRV cocirculate in winter; HRV cases also occur in spring, along with Influenza B (IBV) and other viruses. Despite circulating in the same weeks, the number of observed coinfections was much lower than that predicted for IAV and RSV (p <.0001) and lower also for the IAV/IBV, IBV/RSV and RSV/HRV pairs (p <.0001, p =.0059, p =.015, respectively). IAV and RSV cocirculated with different patterns in different age groups. In fact, in children aged 1-5 years, the RSV peak preceded that of IAV, whereas in older age groups, the RSV peak occurred toward the end of IAV circulation. Sequencing of HRV/EV cases in spring revealed 25 HRV genotypes and two EV-C105 cases.
conclusionsRespiratory viruses can cause age-specific seasonal peaks that are modulated by viral interference phenomena. Molecular diagnostic data should be integrated with surveillance programs to characterize seasonal circulation patterns of common respiratory viruses and to rapidly detect the next pandemic threat.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.